DEVELOPMENT OF FAST-DISSOLVING TABLETS OF AMLODIPINE BESYLATE BY SOLID DISPERSION TECHNOLOGY USING POLOXAMER 407 AND POLOXAMER 188
DOI:
https://doi.org/10.22159/ajpcr.2017.v10i7.17686Keywords:
Amlodipine besylate, Calcium channel blocker, Fast-dissolving tablets, Poloxamer 407, Poloxamer 188, Solid dispersion, SuperdisintergrantsAbstract
Objective: Amlodipine besylate is a calcium channel blocker used in the treatment of hypertension which is practically insoluble in water. The present study aims to design oral fast-release tablets of amlodipine besylate and to optimize the dissolution of the drug by altering the carrier concentration.
Materials and Methods: Poloxamer 407 (P407) and poloxamer 188 (P188) were selected as carriers for the preparation of solid dispersion (SD) by the solvent evaporation method with different drug-polymer ratios. The prepared SDs were evaluated for the physical state, drug:carrier interactions by X-ray diffraction (XRD), infrared spectroscopy, differential scanning calorimetry, and scanning electron microscopy.
Results: From the dissolution studies, it is confirmed that all SDs showed increased dissolution rate when compared to pure amlodipine besylate. Among the two polymers used, P407 was found to be better than P188 in enhancing dissolution efficiency. The tablets were prepared using SD of amlodipine besylate containing P407 as a carrier. The results showed that P407 SD-based tablets gave a significantly higher release of amlodipine besylate when compared with control tablets. The infrared spectral studies showed that there was no significant interaction between amlodipine besylate and its formulation with different polymers used in the preparation of SDs. XRD studies revealed that the degree of crystallinity of amlodipine besylate reduced when the concentration of carriers increased, which reveals that the drug is in amorphous nature.
Conclusion: The combination of SD technology and using superdisintegrants in the formulation is a promising approach for preparing efficient, fast-dissolving tablet of poorly water-soluble drugs, viz., amlodipine besylate.
Downloads
References
Gibaldi M. Biopharmaceutics and Clinical Pharmacokinetics. 4th ed. Philadelphia, PA: Lea & Febiger; 1991.
Nadia S, Riaz U, Naz H, Kumar B. Enhancement of oral bioavailability and solid dispersion: A review. J Appl Pharm Sci 2011;1(7):13-20.
Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50(1):47-60.
Srinarong P, Faber JH, Visser MR, Hinrichs WL, Frijlink HW. Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants. Eur J Pharm Biopharm 2009;73(1):154-61.
Kim EJ, Chun MK, Jang JS, Lee IH, Lee KR, Choi HK. Preparation of a solid dispersion of felodipine using a solvent wetting method. Eur J Pharm Biopharm 2006;64(2):200-5.
Dhirendra K, Lewis S, Udupa N, Atin K. Solid dispersions: A review. Pak J Pharm Sci 2009;22(2):234-46.
Shah PP, Mashru RC. Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique. AAPS PharmSciTech 2008;9(2):494-500.
Newa M, Bhandari KH, Oh DH, Kim YR, Sung JH, Kim JO, et al. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407. Arch Pharm Res 2008;31(11):1497-507.
Newa M, Bhandari KH, Li DX, Kwon TH, Kim JA, Yoo BK,
et al. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm 2007;343(1-2):228-37.
Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm 2004;272(1-2):1-10.
Nirav P, Jayavadan P. Dissolution enhancement of anti depressant escitalopram oxalate by solid dispersion technique. J Curr Pharm Res 2012;9(1):26-32.
Ruchi T, Gaurav T, Birendra S, Awani R. Solid dispersions: An overview to modify to modify bioavailability of poorly water soluble drugs. Int J Pharmtech Res 2009;1(4):1338-49.
Gupta MM, Patel MG, Patel NS, Kedawat M. Enhancement of dissolution rate of ibuprofen by preparing solid dispersion using different methods. Int J Pharm Pharm Sci 2011;3(3):204-6.
Sivakranth M, Altaf AS, Rajasekhar S. Formulation and evaluation of oral fast dissolving tablets of sildinafil citrate. Int J Pharm Pharm Sci 2011;3(2):112-21.
Lalitha Y, Lakshmi PK. Enhancement of dissolution of nifedipine by surface solid dispersion technique. Int J Pharm Pharm Sci 2011;3(3):41-6.
Janssens S, Van den Mooter G. Review: Physical chemistry of solid dispersions. J Pharm Pharmacol 2009;61(12):1571-86.
Kerc J, Mohar M, Sric S, Kofler B, Smid-Korbar J. Dissolution study of felodipine solid dispersions. Acta Pharm Zagrebu 1993;43(2):113-20.
Doherty C, York P. Mechanisms of dissolution of frusemide/PVP solid dispersions. Int J Pharm 1987;34(3):197-5.
Craig DQ, Newton JM. The dissolution of nortriptyline HCL from polyethylene glycol solid dispersions. Int J Pharm 1992;78(1-3):175-82.
Kranthikumar M, Lakshmi PK, Giriprasad VS. Development and evaluation of solid dispersion formulated ibuprofen tablets using cyclodextrins as carrier. Int J Pharm Res Dev 2012;3(11):93-101.
Deshmuk KR, Sunil KJ. Development of aceclofenac mouth dissolving tablets using solid dispersion technique: In-vitro evaluation. Indian J Pharm Educ Res 2012;46(2):97-104.
Jain CP, Naruka PS. Formulation and evaluation of fast dissolving tablets of valsartan. Int J Pharm Pharm Sci 2009;1(1):219-26.
Vijayakumar V, Gunasekharan V, Padmini BS, Kumar JM, Mounica R. Formulation and evaluation of levozcetrizine dihydrochloride fast dissolving tablets using super disintegrants. Int J Pharm Pharm Sci 2013;5(4):324-8.
Patil S, Kuchekar B, Chabukswar A, Jagdale S. Formulation and evaluation of extended-release solid dispersion of metformin hydrochloride. J Young Pharm 2010;2(2):121-9.
Poovi S, Rajpriyadarsini S, Uma S, Vinothini R. Development, characterization and solubility enhancement of comparative dissolution study of second generation of solid dispersions and microspheres for poorly water soluble drug. Asian J Pharm Sci 2015;10(5):433-41.
Onoue S, Sato H, Ogawa K, Kawabata Y, Mizumoto T, Yuminoki K, et al. Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach. Int J Pharm 2010;399(1-2):94-101.
Bley H, Fussnegger B, Bodmeier R. Characterization and stability of solid dispersions based on PEG/polymer blends. Int J Pharm 2010;390(2):165-73.
Xingwang Z, Ningyun S, Baojian W, Yi L, Tianzheng G, Wei W. Physical characterization of lansoprazole/PVP solid dispersion prepared by fluid-bed coating technique. Powder Technol 2008;182(3):480-5.
Veerendra R, Pankaj R, Surender G, Harish D, Gitika A, Manju N. Formulation and characterization of solid dispersion of glimepride through factorial design. Iran J Pharm Sci 2011;7(1):7-16.
Gamal M, Maghraby EI, Ramy E. Fast disintegrating tablets of nisoldipine for intra oral administration . Pharm Dev Technol 2014;19(6):641-50.
Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, et al. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm 2007;66(3):413-21.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.